Only about half of elderly newly diagnosed with ALL receive Tx

(HealthDay)—Almost half of elderly patients newly diagnosed with acute lymphoblastic leukemia (ALL) do not receive treatment, according to a study recently published in Leukemia & Lymphoma. Christopher Kim, M.P.H., Ph.D., from Amgen Inc. in Thousand Oaks, California, and colleagues analyzed Medicare ALL data from 2007 to 2015 to describe patient characteristics and treatment patterns among elderly patients (≥66 years) newly […]

Read more

Drug Repurposing May Provide More Psychiatric Tx Options

FRIDAY, Jan. 11, 2019 — Three classes of drugs hold potential as repurposed agents to treat patients with serious mental illness, according to a study published online Jan. 9 in JAMA Psychiatry. Joseph F. Hayes, Ph.D., from University College London, and colleagues evaluated the repurposing of hydroxylmethyl glutaryl coenzyme A reductase inhibitors (HMG-CoA RIs), L-type calcium channel (LTCC) antagonists, and […]

Read more

Medication beliefs affect uptake of preventive Tx for breast cancer

(HealthDay)—Beliefs about medication are associated with uptake of tamoxifen as a preventive therapy among women at increased risk for breast cancer, according to a study published online Dec. 2 in Clinical Breast Cancer. Rachael Jane Thorneloe, Ph.D., from the University of Leeds in the United Kingdom, and colleagues surveyed 732 women attending an appointment to discuss breast cancer risk. Just […]

Read more